Search
Savara Inc
SVRAAdd to Watchlist
5.460USD
-0.080-1.44%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.12BMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
New Enterprise Associates (NEA)
11.94%
Bain Capital Life Sciences Investors, LLC
7.22%
VR Adviser, LLC
6.71%
Deerfield Management Company, L.P.
6.62%
TCG Crossover Management, LLC
6.03%
Other
61.48%
Shareholders
Shareholders
Proportion
New Enterprise Associates (NEA)
11.94%
Bain Capital Life Sciences Investors, LLC
7.22%
VR Adviser, LLC
6.71%
Deerfield Management Company, L.P.
6.62%
TCG Crossover Management, LLC
6.03%
Other
61.48%
Shareholder Types
Shareholders
Proportion
Investment Advisor
33.21%
Investment Advisor/Hedge Fund
20.16%
Hedge Fund
19.11%
Venture Capital
18.81%
Private Equity
5.98%
Individual Investor
2.58%
Research Firm
1.89%
Bank and Trust
0.27%
Pension Fund
0.04%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
324
213.87M
104.36%
+19.14M
2025Q4
295
181.54M
89.22%
-12.10M
2025Q3
286
169.85M
86.94%
-21.45M
2025Q2
295
181.81M
105.19%
-8.48M
2025Q1
306
176.74M
102.29%
-9.64M
2024Q4
294
173.80M
101.27%
-5.45M
2024Q3
274
169.68M
103.28%
+3.87M
2024Q2
257
157.29M
95.89%
+28.15M
2024Q1
230
131.01M
94.21%
-92.17K
2023Q4
197
123.19M
91.03%
-2.15M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
New Enterprise Associates (NEA)
24.47M
11.96%
--
--
Dec 31, 2025
Bain Capital Life Sciences Investors, LLC
14.79M
7.23%
-2.81M
-15.97%
Dec 31, 2025
VR Adviser, LLC
13.74M
6.71%
+1.06M
+8.35%
Dec 31, 2025
Deerfield Management Company, L.P.
13.57M
6.63%
--
--
Dec 31, 2025
TCG Crossover Management, LLC
12.36M
6.04%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
10.09M
4.93%
+2.49M
+32.79%
Dec 31, 2025
Frazier Life Sciences Management, L.P.
9.86M
4.82%
-1.60M
-13.96%
Dec 31, 2025
Polar Capital LLP
8.31M
4.06%
+8.31M
--
Dec 31, 2025
Nantahala Capital Management, LLC
7.34M
3.59%
-1.43M
-16.30%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Virtus LifeSci Biotech Clinical Trials ETF
1.24%
Texas Capital Texas Small Cap Equity Index ETF
0.24%
ProShares Ultra Nasdaq Biotechnology
0.13%
iShares Micro-Cap ETF
0.09%
Invesco Nasdaq Biotechnology ETF
0.07%
Texas Capital Texas Equity Index ETF
0.05%
iShares Biotechnology ETF
0.03%
ProShares Hedge Replication ETF
0.03%
Invesco RAFI US 1500 Small-Mid ETF
0.03%
iShares Russell 2000 Growth ETF
0.03%
View more
Virtus LifeSci Biotech Clinical Trials ETF
Proportion1.24%
Texas Capital Texas Small Cap Equity Index ETF
Proportion0.24%
ProShares Ultra Nasdaq Biotechnology
Proportion0.13%
iShares Micro-Cap ETF
Proportion0.09%
Invesco Nasdaq Biotechnology ETF
Proportion0.07%
Texas Capital Texas Equity Index ETF
Proportion0.05%
iShares Biotechnology ETF
Proportion0.03%
ProShares Hedge Replication ETF
Proportion0.03%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0.03%
iShares Russell 2000 Growth ETF
Proportion0.03%